Long-term results of a study found combination therapy safe and effective in patients with metastatic urothelial carcinoma or locally advanced disease who are ineligible for cisplatin.
Study sheds light on health disparities in patients with lung cancer.
A recent study found the medication luspatercept helped reduce anemia and transfusion dependence in patients with myelofibrosis.
Combination of EGRF and transforming growth factor beta shows promising results for treating metastatic head and neck squamous cell carcinoma.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Researchers conduct parallel studies to better understand early-onset colorectal cancer.
The Community Outreach group at Cleveland Clinic’s Taussig Cancer Center sought input from people at local faith-based organizations to better understand and address the history of health disparities in the community.
Cleveland Clinic shares top research abstracts to check out at the 2023 ASCO annual meeting.